Рет қаралды 806
Radiation Therapy is used everyday to treat and cure cancer, however, can the radiation doses we receive during therapy also make us sick? ...That is what we discuss in this video.
Further Resources and Information on Radiotherapy:
www.cancer.gov/about-cancer/t...
www.cancer.org/cancer/managin...
www.iaea.org/resources/rpop/p...
www.nhsinform.scot/tests-and-...
REFERENCES
Effects of Radiotherapy
www.cancer.gov/about-cancer/t...
www.cancer.org/cancer/managin...
www.cancer.gov/about-cancer/c...
Rheingold et al, Therapy-Related Secondary Cancers,
Holland-Frei Cancer Medicine, 6th Ed, Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003. [www.ncbi.nlm.nih.gov/books/NB...]
Dracham CB, Shankar A, Madan R. Radiation induced secondary malignancies: a review article. Radiat Oncol J. 2018 Jun;36(2):85-94. doi: 10.3857/roj.2018.00290, 2018.
König L et al. Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers (Basel). 13;14(10):2409, 2022, doi: 10.3390/cancers14102409.
Eaton BR, MacDonald SM, Yock TI, Tarbell NJ. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015 Nov 26;5:261. doi: 10.3389/fonc.2015.00261.
Schneider U. Modeling the risk of secondary malignancies after radiotherapy. Genes (Basel). 2011 Nov 29;2(4):1033-49. doi: 10.3390/genes2041033.
Risk vs Benefit
www.cancer.gov/about-cancer/t...
www.cancer.org/cancer/managin...
Chiang JS et al. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations. J Thorac Dis. 2021 Feb;13(2):1270-1285. doi: 10.21037/jtd-20-2501.
American Society of Clinical Oncology . Non-small cell lung cancer: Statistics. 2019.
U.S. National Institute Of Health, National Cancer Institute. SEER Cancer Statistics Review, 1975-2015.
www.cancer.org/cancer/types/l....
www.cancer.org/cancer/types/l...
Chang JY, Zhang W, Komaki R, et al. Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol 2017;122:274-80. 10.1016/j.radonc.2016.10.022
Verma V, et al. Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041.
www.cancer.org/cancer/types/b...
www.cancer.org/cancer/types/c....
www.cancer.org/cancer/types/l...
www.cancer.org/cancer/types/c...
www.cancer.net/cancer-types/l...
www.cancer.org/cancer/types/b...
www.nationalbreastcancer.org/...
www.cancer.org/cancer/types/p...
www.cancer.net/cancer-types/p....
Open Source images used in this video
openclipart.org/detail/340884...
commons.wikimedia.org/wiki/Fi...
commons.wikimedia.org/wiki/Fi...
www.dovepress.com/getfile_art...
freesvg.org/1534127190
pixabay.com/vectors/cell-cell...
www.istockphoto.com/vector/mr...